Not available
Quote | Akari Therapeutics Plc (NASDAQ:AKTX)
Last: | $1.1799 |
---|---|
Change Percent: | -0.85% |
Open: | $1.185 |
Close: | $1.19 |
High: | $1.1999 |
Low: | $1.17 |
Volume: | 1,647 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Akari Therapeutics Plc (NASDAQ:AKTX)
BOSTON and LONDON, April 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will present new pre-clinical data on investigational long-acting PAS-nomacopan...
2024-04-01 06:59:12 ET More on Akari Therapeutics Akari Therapeutics rises on all-stock merger deal with Peak Bio Financial information for Akari Therapeutics Read the full article on Seeking Alpha For further details see: Akari Therapeutics Non-GAAP EPS ...
Message Board Posts | Akari Therapeutics Plc (NASDAQ:AKTX)
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Rogerthat1 | investorshub | 07/03/2023 10:19:08 PM |
$AKTX Good read | mick | investorshub | 07/03/2023 6:42:07 PM |
$AKTX The gaining | mick | investorshub | 07/03/2023 5:19:37 PM |
The now up | mick | investorshub | 07/02/2023 1:19:36 PM |
The gaining up | mick | investorshub | 07/01/2023 11:35:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Akari Therapeutics Plc Company Name:
AKTX Stock Symbol:
NASDAQ Market:
BOSTON and LONDON, April 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will present new pre-clinical data on investigational long-acting PAS-nomacopan...
BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights. ...
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...